Your browser doesn't support javascript.
loading
Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma.
Bu, De-Xiu; Singh, Reshma; Choi, Eugene E; Ruella, Marco; Nunez-Cruz, Selene; Mansfield, Keith G; Bennett, Paul; Barton, Nathanial; Wu, Qilong; Zhang, Jiquan; Wang, Yongqiang; Wei, Lai; Cogan, Shawn; Ezell, Tucker; Joshi, Shree; Latimer, Kellie J; Granda, Brian; Tschantz, William R; Young, Regina M; Huet, Heather A; Richardson, Celeste J; Milone, Michael C.
Afiliación
  • Bu DX; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Singh R; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Choi EE; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Ruella M; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Nunez-Cruz S; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Mansfield KG; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Bennett P; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Barton N; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Wu Q; China Novartis Institutes for Biomedical Research, Shanghai 201203, China.
  • Zhang J; China Novartis Institutes for Biomedical Research, Shanghai 201203, China.
  • Wang Y; China Novartis Institutes for Biomedical Research, Shanghai 201203, China.
  • Wei L; China Novartis Institutes for Biomedical Research, Shanghai 201203, China.
  • Cogan S; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Ezell T; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Joshi S; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Latimer KJ; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Granda B; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Tschantz WR; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Young RM; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Huet HA; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Richardson CJ; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
  • Milone MC; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
Oncotarget ; 9(40): 25764-25780, 2018 May 25.
Article en En | MEDLINE | ID: mdl-29899820
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos